Alaa Halawa's most recent trade in Neumora Therapeutics Inc. was a trade of 46,455 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Neumora Therapeutics Inc. | Alaa Halawa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 46,455 | 46,455 | - | - | Stock Option (Right to Buy) | |
Neumora Therapeutics Inc. | Alaa Halawa | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 46,455 | 0 | - | - | Stock Option (Right to Buy) | |
Neumora Therapeutics Inc. | Alaa Halawa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,571 | 28,571 | - | - | Stock Option (Right to Buy) | |
Neumora Therapeutics Inc. | Alaa Halawa | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 28,571 | 0 | - | - | Stock Option (Right to Buy) | |
Neumora Therapeutics Inc. | Alaa Halawa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 28,571 | 28,571 | - | - | Stock Option (Right to Buy) | |
Neumora Therapeutics Inc. | Alaa Halawa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 20,100 | 20,100 | - | 0 | Common Stock |